A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer

✍ Scribed by Eisenhauer, Eric L.; Zanagnolo, Vanna; Cohn, David E.; Salani, Ritu; O'Malley, David M.; Sutton, Gregory; Callahan, Michael J.; Cobb, Bobbi; Fowler, Jeffrey M.; Copeland, Larry J.

• Book ID: 124138185
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 430 KB
• Volume: 134
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2014.05.030